Consortium Biospecimen Resource

The Cancer Consortium Biospecimen Resource (CBR) was founded with the understanding that major biomedical advances in this country relating to detection, treatment, and prevention of solid tumor cancers have been achieved through access to biospecimens.  To catalyze cancer research and biomarker discovery, the CBR will provide investigators with a comprehensive biospecimen collection and distribution system that meets the detailed requirements of their research protocols and all applicable human subjects regulations.  When fully-implemented, two services will link investigators to high-quality, annotated human biospecimens:

1.  Investigators will be able to search existing Consortium repositories for biospecimens that are potentially available for new research studies

2.  The CBR will prospectively collect and distribute research tissue and/or blood specimens from surgeries and clinic procedures at Consortium facilities.

Development of the CBR is made possible by a grant from the Washington State Life Sciences Discovery Fund (LSDF) and institutional support from the partners of the Cancer Consortium: Fred Hutchinson Cancer Research Center, University of Washington (primarily through the Institute of Translational Health Sciences (ITHS)), Seattle Children’s (SC) and Seattle Cancer Care Alliance (SCCA).